No abstract available
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / mortality
-
Adenocarcinoma / pathology
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Clinical Trials, Phase II as Topic
-
Disease-Free Survival
-
Esophageal Neoplasms / drug therapy*
-
Esophageal Neoplasms / mortality
-
Esophageal Neoplasms / pathology*
-
Esophageal Squamous Cell Carcinoma / drug therapy*
-
Esophageal Squamous Cell Carcinoma / mortality
-
Esophageal Squamous Cell Carcinoma / pathology
-
Humans
-
Neoplasm Invasiveness / pathology
-
Neoplasm Metastasis
-
Neoplasm Staging
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Survival Analysis